The week’s top gainer was Ocular Therapeutix, followed by Cara Therapeutics, Immunomedics, Rockwell Medical and Array BioPharma.
By Pia Rivera
Last week’s top gainer was PTC Therapeutics followed by Cogentix Medical, Concordia International, Galectin Therapeutics and XOMA.
By Vivien Diniz
AveXis, Inc., announced patient enrollment has completed for the Phase 1 clinical trial of AVXS-101 for the treatment of spinal muscular atrophy (SMA) Type 1.